LDLR and atherosclerosis: Recombinant mouse IL-2/anti-IL-2 monoclonal antibody complexes (IL-2 complexes) efficiently and selectively expand CD4+CD25+Foxp3+ Tregs and attenuate atherosclerosis in Ldlr−/− [112] or Apoe−/− mice [113].